(PDF) Transmembrane Protein Polymorphisms and Resistance to

Transmembrane Protein Polymorphisms and Resistance to T-20 (Enfuvirtide, Fuzeon®) in HIV-1 Infected Therapy-Naive Seroconverters and AIDS Patients Under HAART-T-20 Therapy

Virus Genes - Netherlands

doi 10.1007/s11262-007-0111-2

Full Text

Open PDF

Abstract

Available in full text

Date

May 17, 2007

Authors

Publisher

Springer Science and Business Media LLC

Related search

Relative Replicative Fitness of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide (T-20)

English

Analysis of Primary Resistance Mutations to HIV-1 Entry Inhibitors in Therapy Naive Subtype C HIV-1 Infected Mother–infant Pairs From Zambia

Journal of Clinical Virology

Virology

Infectious Diseases

2013

English

Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated With Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults

International Journal of Chronic Diseases

2018

English

Vision 20∕20: Proton Therapy

English

Time to Death Predictors of HIV/AIDS Infected Patients on Antiretroviral Therapy in Ethiopia

English

Comparison of Antiretroviral Therapy Regimens With Regard to Virological and Immunological Response in Treatment-Naive HIV/AIDS Patients

English

Alteration in Lipid Profile in Treatment-Naive HIV-Infected Patients and Changes Following HAART Initiation in Haryana

Journal of Endocrinology and Metabolism

English

Investigation of HIV-1 Primary Drug Resistance Mutations in Antiretroviral Therapy-Naive Cases

Mikrobiyoloji Bulteni

English

Impact of Cigarette and Alcohol Use on Adverse Drug Reactions of Haart Therapy Among HIV/AIDS Patients

English

Amanote Research

Transmembrane Protein Polymorphisms and Resistance to T-20 (Enfuvirtide, Fuzeon®) in HIV-1 Infected Therapy-Naive Seroconverters and AIDS Patients Under HAART-T-20 Therapy

Virus Genes - Netherlands

doi 10.1007/s11262-007-0111-2

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Relative Replicative Fitness of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide (T-20)

Analysis of Primary Resistance Mutations to HIV-1 Entry Inhibitors in Therapy Naive Subtype C HIV-1 Infected Mother–infant Pairs From Zambia

Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated With Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults

Vision 20∕20: Proton Therapy

Time to Death Predictors of HIV/AIDS Infected Patients on Antiretroviral Therapy in Ethiopia

Comparison of Antiretroviral Therapy Regimens With Regard to Virological and Immunological Response in Treatment-Naive HIV/AIDS Patients

Alteration in Lipid Profile in Treatment-Naive HIV-Infected Patients and Changes Following HAART Initiation in Haryana

Investigation of HIV-1 Primary Drug Resistance Mutations in Antiretroviral Therapy-Naive Cases

Impact of Cigarette and Alcohol Use on Adverse Drug Reactions of Haart Therapy Among HIV/AIDS Patients